Longevity marketing loves two villains: bad genes and nutrient deficiency. The solution is then conveniently sold in a bottle.
Twin research does not support such a tidy story.
Quick answer
If longevity is heritable, can supplements overcome genetics?
There is no evidence for a general supplement strategy that overrides genetic lifespan susceptibility. Lifespan is shaped by many inherited and non-inherited influences, and the heritability estimate itself depends on how mortality is modelled.
Key takeaways
- Classic twin data show that much lifespan variation is non-genetic.
- New 2026 modelling argues intrinsic lifespan may be more heritable once extrinsic mortality is separated.
- Both findings concern populations, not personal destiny.
- No general vitamin or multivitamin has been shown to erase inherited longevity risk.
Longevity is not one mechanism
Cancer, cardiovascular disease, infection, accidents, neurodegeneration and many other pathways contribute to age at death.
A supplement would need to affect relevant pathways and outcomes — not simply move a biomarker.
Heritability is not modifiability
A trait can be highly heritable and still modifiable, or weakly heritable and difficult to change.
Using heritability as a shopping guide for supplements is therefore conceptually wrong.
The useful longevity question
Instead of asking which pill makes us live longer, ask which behaviours, prevention strategies and clinical treatments have evidence for the outcomes that matter.
Supplements belong inside that evidence hierarchy, not above it.
Source notes
The sources have been verified and editorially reviewed for this article. The limitations below show which level of conclusion the sources support.
- [herskind-1996] The heritability of human longevity: a population-based study of 2872 Danish twin pairs born 1870-1900 A. M. Herskind et al.. Human Genetics, 1996. Evidence type: Population-based Danish twin lifespan analysis Limitation: Classic twin modelling estimated moderate longevity heritability around one quarter in this historical cohort; the estimate depends on model and definition. PubMed DOI
- [shenhar-2026] Heritability of intrinsic human life span is about 50% when confounding factors are addressed Ben Shenhar et al.. Science, 2026. Evidence type: Mathematical modelling and twin-cohort analyses separating intrinsic from extrinsic mortality Limitation: This newer estimate addresses intrinsic lifespan after modelling extrinsic mortality and should not be presented as directly overturning every earlier lifespan estimate; it answers a narrower modelling question. PubMed DOI
- [loftfield-2024] Multivitamin Use and Mortality Risk in 3 Prospective US Cohorts Erikka Loftfield et al.. JAMA Network Open, 2024. Evidence type: Prospective cohort analysis of 390,124 generally healthy adults Limitation: Daily multivitamin use was not associated with lower all-cause mortality. Observational exposure data cannot prove harm or benefit on their own. PubMed DOI
Editorial source review
This section shows how the article's key factual claims are linked to the source.
Phrasings that require caution
- Do not promise longevity from supplements.
- Do not use lifespan heritability to motivate supplement sales.
| ID | Claim | Source support | Caution |
|---|